Paragon 28 Inc (FNA)
6.06
+0.44
(+7.83%)
USD |
NYSE |
Nov 04, 16:00
6.065
0.00 (0.00%)
After-Hours: 20:00
Paragon 28 Research and Development Expense (Annual): 30.08M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.08M |
| December 31, 2022 | 24.65M |
| December 31, 2021 | 16.13M |
| Date | Value |
|---|---|
| December 31, 2020 | 11.17M |
| December 31, 2019 | 10.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
10.30M
Minimum
2019
30.08M
Maximum
2023
18.46M
Average
16.13M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Outset Medical Inc | 57.31M |
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |